These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 4148604)

  • 1. Effects of acute and chronic administration of desmethylimipramine on the content of norepinephrine and other monoamines in the rat brain.
    Roffler-Tarlov S; Schildkraut JJ; Draskoczy PR
    Biochem Pharmacol; 1973 Nov; 22(22):2923-6. PubMed ID: 4148604
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of 4-chlorophenoxyamphetamine (A-6587), d-amphetamine and 4-chloroamphetamine on brain biogenic amines and behavior in mice.
    Everett GM; Yellin TO
    Res Commun Chem Pathol Pharmacol; 1971; 2(4):407-13. PubMed ID: 4400361
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the effectiveness of deserpidine, reserpine, and alpha-methyltyrosine on brain biogenic amines.
    Fulton SC; Healy MD
    Fed Proc; 1976 Dec; 35(14):2558-62. PubMed ID: 11134
    [No Abstract]   [Full Text] [Related]  

  • 4. Differences between the effects of acute and long-term treatment with desmethylimipramine on reserpine-induced release of amines from rat brain.
    Roffler-Tarlov S
    Biochem Pharmacol; 1975 Jul; 24(13-14):1321-5. PubMed ID: 1148020
    [No Abstract]   [Full Text] [Related]  

  • 5. Behavioral and biochemical interactions of 5,7-dihydroxytryptamine with various drugs when administered intracisternally to adult and developing rats.
    Breese GR; Cooper BR
    Brain Res; 1975 Nov; 98(3):517-27. PubMed ID: 1242372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Norepinephrine metabolism in the rat brain following acute and chronic administration of thyrotropin releasing hormone.
    Reigle TG; Avni J; Platz PA; Schildkraut JJ; Plotnikoff NP
    Psychopharmacologia; 1974 Jun; 37(1):1-6. PubMed ID: 4213267
    [No Abstract]   [Full Text] [Related]  

  • 7. Evidence of a role for brain monoamines in ethanol dependence.
    Griffiths PJ; Littleton JM; Oritz A; Brownlee G
    Br J Pharmacol; 1973 Jun; 48(2):354P. PubMed ID: 4147432
    [No Abstract]   [Full Text] [Related]  

  • 8. Biogenic amines and related enzymes in the circumventricular organs of the rat.
    Saavedra JM; Brownstein MJ; Kizer JS; Palkovits M
    Brain Res; 1976 May; 107(2):412-7. PubMed ID: 5177
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible role of brain monoamines in pentobarbitone induced hypothermia in albino rats.
    Rao YV; Acharya SB; Sanyal AK
    Indian J Exp Biol; 1982 Jan; 20(1):60-3. PubMed ID: 7118196
    [No Abstract]   [Full Text] [Related]  

  • 10. Some effects of the acute and chronic administration of sex hormones on brain monoamine concentrations.
    Greengrass PM; Tonge SR
    Br J Pharmacol; 1973 Mar; 47(3):660P-661P. PubMed ID: 4730870
    [No Abstract]   [Full Text] [Related]  

  • 11. Biogenic amine-depleting effects of benzimidazole-5(6)-DL-alanine.
    Johnson EM; Zenker N; Wright J
    Biochem Pharmacol; 1972 Jul; 21(13):1777-83. PubMed ID: 4646181
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of chronic diazepam and medazepam treatment on the level of biogenic monoamines in different rat brain areas.
    Stancheva S; Petkov VV
    Acta Physiol Pharmacol Bulg; 1988; 14(3):26-31. PubMed ID: 2906206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of L-dopa on self-stimulation and brain biogenic amines in rats.
    Nimitkitpaisan Y; Bose S; Kumar R; Pradhan SN
    Neuropharmacology; 1977 Oct; 16(10):657-61. PubMed ID: 593529
    [No Abstract]   [Full Text] [Related]  

  • 14. The effect of amantadine on radiolabeled biogenic amines in the rat brain.
    Symchowicz S; Korduba CA; Veals J
    Eur J Pharmacol; 1973 Feb; 21(2):155-60. PubMed ID: 4696098
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparative analysis of the concentration of monoamines in the brain of the rat during food and water deprivation].
    Timofeev NA; Timofeeva LV; Varsegi M; Kadar T; Zhuravlev BV
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1984; 34(5):980-1. PubMed ID: 6506881
    [No Abstract]   [Full Text] [Related]  

  • 16. Influence of desmethylimipramine on some neurochemical alterations during experimental hypothyroidism.
    Rastogi RB; Singhal RL; Hrdina PD
    Neuropharmacology; 1975 Oct; 14(10):747-53. PubMed ID: 638
    [No Abstract]   [Full Text] [Related]  

  • 17. [Changes in the concentration of biogenic monoamines in different brain regions under the influence of centrophenoxine (experiments on rats)].
    Petkov V; Konstantinova E; Zafirov D; Stancheva S
    Eksp Med Morfol; 1976; 15(4):233-6. PubMed ID: 189988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurochemical changes following the administration of depleters of biogenic monoamines.
    Lane JD; Smith JE; Shea PA; McBride WJ
    Life Sci; 1976 Dec; 19(11):1663-7. PubMed ID: 12434
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of electroconvulsive shock on brain monoamines].
    Kuang PG
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Feb; 18(1):41-4. PubMed ID: 2580677
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of three dihydroxylated derivatives of tryptamine on the behavior and on brain amine content in mice.
    Massotti M; Scotti de Carolis A; Longo VG
    Pharmacol Biochem Behav; 1974; 2(6):769-76. PubMed ID: 4549398
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.